IPBronch.com | Interventional Pulmonology

Chest Jul 1, 2026

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Study Takeaway

Relevant for IP clinicians involved in lung cancer screening programs and the management of screen-detected nodules.

Liu H; Yan S; Liu P; Zhang C; Wang Q; Shen Q

IP Score: 6/10 View Analysis →

Thorax Jun 25, 2026

Comparative cost-effectiveness of screening for lung cancer using different risk scores and thresholds: the Yorkshire Lung Screening Trial.

Study Takeaway

Optimizing screening criteria will likely increase the volume of screen-detected nodules requiring IP diagnostic intervention.

Zhang Y; Hinde S; Marshall CS; Hancock N; Simmonds I; Soares M

IP Score: 6/10 View Analysis →

Thorax Jun 17, 2026

Sex differences in immunotherapy for lung cancer: balance or bias?

Study Takeaway

Understanding sex-based differences in immunotherapy response is increasingly important for IP clinicians involved in the diagnostic and staging pathways of lung cancer.

Mascarenhas E; Cordeiro de Lima VC

IP Score: 6/10 View Analysis →

Thorax Jun 15, 2026

Multimodality curative-intent treatment in NSCLC: an unprecedented era of change 2017-2025.

Study Takeaway

IPs must stay updated on these systemic therapy shifts as they influence the timing and necessity of diagnostic and staging bronchoscopy in the multimodality care pathway.

Evison M; Ahmed T; Chitnis M; Ward R; Netto D; Cove-Smith L

IP Score: 6/10 View Analysis →

Respiratory medicine Jun 9, 2026

Lung Cancer Location Drives Lateralized Ventilation Loss and Adverse Outcome.

Study Takeaway

Understanding tumor-related ventilation loss is relevant for IP clinicians performing bronchoscopic lung volume reduction or planning diagnostic biopsies in compromised lungs.

Yu K; Wang H; Li C; Cheng B; Zheng X; Chen P

IP Score: 6/10 View Analysis →

Chest May 29, 2026

Smoking-Related Comorbidities Detected Through Low-dose CT Lung Cancer Screening: Current Evidence and Future Directions.

Study Takeaway

Highlights the importance of multidisciplinary management for incidental findings detected during lung cancer screening, which often leads to IP referral for diagnostic biopsy.

Revel MP; Goo JM; Vliegenthart R; Silva M; Snoeckx A

IP Score: 7/10 View Analysis →

Respiratory research May 23, 2026

Comprehensive characterization of MET exon 14 skipping mutations in non-small cell lung cancer.

Study Takeaway

Relevant for IP clinicians involved in tissue acquisition and molecular profiling for lung cancer diagnostics.

Lin J; Xia G; Wu Y; Chen L; Zhang Y; Ma Y

IP Score: 6/10 View Analysis →

Chest May 18, 2026

Natural history, treatment, survival, and causes of mortality in patients with subsolid and ground-glass nodules.

Study Takeaway

Provides critical context for the decision-making process regarding when to pursue diagnostic bronchoscopy versus radiographic surveillance for indeterminate nodules.

Bader JM; Prince SR; de Santis W; Kane ER; Tanoue L; Bader AS

IP Score: 7/10 View Analysis →

American journal of respiratory and critical care medicine May 4, 2026

Toward Precision in Lung Cancer: Screening, Susceptibility, and Therapeutic Resistance.

Study Takeaway

Highlights the evolving landscape of lung cancer management, which informs the diagnostic and staging roles of interventional pulmonologists in the era of precision oncology.

Nana-Sinkam P

IP Score: 6/10 View Analysis →

Journal of thoracic oncology May 2, 2026

Emerging Targeted Therapies for HER2-mutant Non-Small Cell Lung Cancer.

Study Takeaway

Relevant for IP clinicians involved in the diagnostic workup and tissue acquisition for molecular profiling in lung cancer patients.

Del Rio B; Masini S; Cáceres-Galvis C; Torres-Jiménez J; Bote H; Zurera M

IP Score: 6/10 View Analysis →

Journal of thoracic oncology Apr 27, 2026

Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma.

Study Takeaway

Relevant for IP clinicians performing diagnostic biopsies and staging, as these histologic features are often identified on tissue samples obtained via bronchoscopy.

Abolfathi H; Maranda-Robitaille M; Lamaze FC; Kordahi M; Armero VS; Orain M

IP Score: 6/10 View Analysis →

Respirology Mar 25, 2026

The Implications of 9th Lung Cancer TNM Classification on Interventional Pulmonology

Study Takeaway

Essential reading for IP clinicians to understand changes in staging criteria that dictate biopsy and nodal sampling strategies.

Authors not listed

IP Score: 9/10 View Analysis →

Literature Archives